A new active vitamin D3 analog, eldecalcitol, prevents the risk of osteoporotic fractures - A randomized, active comparator, double-blind study

Bone

Volumn 49, Issue 4, 2011, Pages 605-612

  Matsumoto, Toshio ^a   Ito, Masako ^b   Hayashi, Yasufumi ^c   Hirota, Takako ^d   Tanigawara, Yusuke ^e   Sone, Teruki ^f   Fukunaga, Masao ^f   Shiraki, Masataka ^g   Nakamura, Toshitaka ^h  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

^c Tokyo Metropolitan Rehabilitation Hospital   (Japan)

^d KYOTO KOKA WOMEN'S UNIVERSITY   (Japan)

^e KEIO UNIVERSITY   (Japan)

^f KAWASAKI MEDICAL SCHOOL   (Japan)

^g RESEARCH INSTITUTE AND PRACTICE FOR INVOLUTIONAL DISEASES   (Japan)

^h UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Active vitamin D; Bone mineral density; Osteoporosis; Vertebral fracture; Wrist fracture

Indexed keywords

1,25 DIHYDROXYERGOCALCIFEROL; 25 HYDROXYVITAMIN D; ALFACALCIDOL; ALKALINE PHOSPHATASE; AMINO TERMINAL TELOPEPTIDE; COLECALCIFEROL; ELDECALCITOL; PARATHYROID HORMONE;

ADULT; AGED; ARTHRALGIA; ARTICLE; BACKACHE; BONE DENSITY; BONE TURNOVER; CALCIUM BLOOD LEVEL; CALCIUM EXCRETION; CALCIUM INTAKE; CALCIUM METABOLISM; CALCIUM URINE LEVEL; CATARACT; CONSTIPATION; CONTACT DERMATITIS; CONTROLLED STUDY; CONTUSION; CYSTITIS; DIARRHEA; DISEASE COURSE; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FATALITY; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; ECZEMA; FEMALE; FRAGILITY FRACTURE; GASTRITIS; GASTROENTERITIS; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; INCIDENCE; INSOMNIA; LEG PAIN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; OSTEOARTHRITIS; OSTEOLYSIS; RANDOMIZED CONTROLLED TRIAL; RASH; RHINOPHARYNGITIS; RISK FACTOR; SIDE EFFECT; SPINE DISEASE; SPINE FRACTURE; SPRAIN; STOMACH DISCOMFORT; STOMATITIS; UROLITHIASIS; VERTEBRA FRACTURE; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; WRIST FRACTURE;

AGED; AGED, 80 AND OVER; BONE DENSITY; BONE REMODELING; CHOLECALCIFEROL; DOUBLE-BLIND METHOD; FEMALE; HORMONES; HUMANS; INCIDENCE; JAPAN; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; OSTEOPOROTIC FRACTURES; RISK FACTORS; SPINAL FRACTURES; TREATMENT OUTCOME; VITAMIN D;

EID: 80052278079     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2011.07.011     Document Type: Article

References (26)

1. Miyamoto K., Murayama E., Ochi K., Watanabe H., Kubodera N. Synthetic studies of vitamin D analogues. XIV. Synthesis and calcium regulating activity of vitamin D3 analogues bearing a hydroxyalkoxy group at the 2 beta-position. Chem Pharm Bull (Tokyo) 1993, 41:1111-1113.
2. Tsurukami H., Nakamura T., Suzuki K., Sato K., Higuchi Y., Nishii Y. A novel synthetic vitamin D analogue, 2 beta-(3-hydroxypropoxy)1 alpha, 25-dihydroxyvitamin D3 (ED-71), increases bone mass by stimulating the bone formation in normal and ovariectomized rats. Calcif Tissue Int 1994, 54:142-149.
3. Uchiyama Y., Higuchi Y., Takeda S., Masaki T., Shira-ishi A., Sato K., et al. ED-71, a vitamin D analog, is a more potent inhibitor of bone resorption than alfacalcidol in an estrogen-deficient rat model of osteoporosis. Bone 2002, 30:582-588.
4. Matsumoto T., Kubodera N., Group T.E.-S. 1alpha,25-Dihydroxy-2beta-(3-hydroxypropoxy) vitamin D3 (ED-71): a promising candidate for the treatment of osteoporosis 2000, 985-992. Vitamin D Workshop, Inc., University of California, Riverside.
5. Kubodera N., Tsuji N., Uchiyama Y., Endo K. A new active vitamin D analog, ED-71, causes increase in bone mass with preferential effects on bone in osteoporotic patients. J Cell Biochem 2003, 88:286-289.
6. Matsumoto T., Miki T., Hagino H., Sugimoto T., Okamoto S., Hirota T., et al. A new active vitamin D, ED-71, increases bone mass in osteoporotic patients under vitamin D Supplementation: a randomized, double-blind, placebo-controlled clinical trial. J Clin Endocrinol Metab 2005, 90:5031-5036.
7. Matsumoto T., Kubodera N. ED-71, a new active vitamin D3, increases bone mineral density regardless of serum 25(OH)D levels in osteoporotic subjects. J Steroid Biochem Mol Biol 2007, 103:584-586.
8. Hayashi Y., Fujita T., Inoue T. Decrease of vertebral fracture in osteoporotics by administration of 1alpha-hydroxy-vitamin D3. J Bone Miner Metab 1992, 10:184-188.
9. Orimo H., Shiraki M., Hayashi Y., Hoshino T., Onaya T., Miyazaki S., et al. Effects of 1 alpha-hydroxyvitamin D3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosis. Calcif Tissue Int 1994, 54:370-376.
10. Shiraki M., Kushida K., Yamazaki K., Nagai T., Inoue T., Orimo H. Effects of 2years' treatment of osteoporosis with 1 alpha-hydroxy vitamin D3 on bone mineral density and incidence of fracture: a placebo-controlled, double-blind prospective study. Endocr J 1996, 43:211-220.
11. Ishida Y., Kawai S. Comparative efficacy of hormone replacement therapy, etidronate, calcitonin, alfacalcidol, and vitamin K in postmenopausal women with osteoporosis: the Yamaguchi Osteoporosis Prevention Study. Am J Med 2004, 117:549-555.
12. Matsumoto T., Takano T., Yamakido S., Takahashi F., Tsuji N. Comparison of the effects of eldecalcitol and alfacalcidol on bone and calcium metabolism. J Steroid Biochem Mol Biol 2010, 121:261-264.
13. Orimo H., Sugioka Y., Fukunaga M., Muto Y., Hotokebuchi T., Gorai I., et al. Diagnostic criteria of primary osteoporosis. J Bone Miner Metab 1998, 16:139-150.
14. Orimo H., Hayashi Y., Fukunaga M., Sone T., Fujiwara S., Shiraki M., et al. Diagnostic criteria for primary osteoporosis: year 2000 revision. J Bone Miner Metab 2001, 19:331-337.
15. Genant H.K., Wu C.Y., van Kuijk C., Nevitt M.C. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 1993, 8:1137-1148.
16. Fukunaga M., Nakamura T., Shiraki M., Kuroda T., Ohta H., Hosoi T., et al. Absolute height reduction and percent height ratio of the vertebral body in incident fracture in Japanese women. J Bone Miner Metab 2004, 22:104-110.
17. Papadimitropoulos E., Wells G., Shea B., Gillespie W., Weaver B., Zytaruk N., et al. Meta-analyses of therapies for postmenopausal osteoporosis. VIII: meta-analysis of the efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women. Endocr Rev 2002, 23:560-569.
18. Tilyard M.W., Spears G.F., Thomson J., Dovey S. Treatment of postmenopausal osteoporosis with calcitriol or calcium. N Engl J Med 1992, 326:357-362.
19. de Freitas P.H., Hasegawa T., Takeda S., Sasaki M., Tabata C., Oda K., et al. Eldecalcitol, a second-generation vitamin D analog, drives bone minimodeling and reduces osteoclastic number in the trabecular bone of ovariectomized rats. Bone 2011, 49:335-342.
20. Ito M., Nakamura T., Fukunaga M., Shiraki M., Matsumoto T. Effect of eldecalcitol, an active vitamin D analog, on hip structure and biomechanical properties: 3D assessment by clinical CT. Bone 2011, 49:328-334.
21. Bischoff-Ferrari H.A., Dawson-Hughes B., Willett W.C., Staehelin H.B., Bazemore M.G., Zee R.Y., et al. Effect of Vitamin D on falls: a meta-analysis. JAMA 2004, 291:1999-2006.
22. Bischoff-Ferrari H.A., Dawson-Hughes B., Staehelin H.B., Orav J.E., Stuck A.E., Theiler R., et al. Fall prevention with Supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ 2009, 339:b3692.
23. Bischoff-Ferrari H.A., Conzelmann M., Stahelin H.B., Dick W., Carpenter M.G., Adkin A.L., et al. Is fall prevention by vitamin D mediated by a change in postural or dynamic balance?. Osteoporos Int 2006, 17:656-663.
24. Faulkner K.A., Cauley J.A., Zmuda J.M., Landsittel D.P., Newman A.B., Studenski S.A., et al. Higher 1,25-dihydroxyvitamin D3 concentrations associated with lower fall rates in older community-dwelling women. Osteoporos Int 2006, 17:1318-1328.
25. Minasyan A., Keisala T., Zou J., Zhang Y., Toppila E., Syvala H., et al. Vestibular dysfunction in vitamin D receptor mutant mice. J Steroid Biochem Mol Biol 2009, 114:161-166.
26. Barr R., Macdonald H., Stewart A., McGuigan F., Rogers A., Eastell R., et al. Association between vitamin D receptor gene polymorphisms, falls, balance and muscle power: results from two independent studies (APOSS and OPUS). Osteoporos Int 2010, 21:457-466.